oritavancin structure 
             | 
        Common Name | oritavancin | ||
|---|---|---|---|---|
| CAS Number | 171099-57-3 | Molecular Weight | 1793.10000 | |
| Density | N/A | Boiling Point | N/A | |
| Molecular Formula | C86H97Cl3N10O26 | Melting Point | N/A | |
| MSDS | N/A | Flash Point | N/A | |
            Use of oritavancinOritavancin (LY 333328) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin shows antibacterial effect against multidrug-resistant S. pneumoniae. Oritavancin inhibits cell wall synthesis and disrupts the membrane potential[1][2].  | 
    
| Name | oritavancin | 
|---|---|
| Synonym | More Synonyms | 
| Description | Oritavancin (LY 333328) is an orally active glycopeptide antibiotic with activity against gram-positive organisms. Oritavancin shows antibacterial effect against multidrug-resistant S. pneumoniae. Oritavancin inhibits cell wall synthesis and disrupts the membrane potential[1][2]. | 
|---|---|
| Related Catalog | |
| References | 
| Molecular Formula | C86H97Cl3N10O26 | 
|---|---|
| Molecular Weight | 1793.10000 | 
| Exact Mass | 1790.56000 | 
| PSA | 560.98000 | 
| LogP | 8.57000 | 
| Hazard Codes | Xn | 
|---|
| LY333328 | 
| Orbactiv |